Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-16T16:42:18.772Z Has data issue: false hasContentIssue false

What Has Clinical Research in Suicide Prevention Done for You Lately?

Published online by Cambridge University Press:  07 November 2014

Extract

What have you heard or read over the past 10 years that has improved you ability to assess and manage suicide risk in your patients?

There has been a paucity of data. What little data there is reviewed in this month's articles.They highlight findings that you should know about. Clinicians seem to cling to the familiar, unless some intense marketing is done.

For instance, are you aware that the current evidence shows that a denial of suicide thoughts, plans, or intent—even a contract for safety—means absolutely nothing in the absence of a full suicide risk assessment?

Yet clinicians seem to rely on these ’reassurances“ from their patients and are shocked when the patient later commits suicide. Why should a patient who is deciding that life is too painful to live tell you the truth? Robert I. Simon, MD, and Daniel W. Shuman, JD, review these facts.

Are you aware that severe psychic anxiety, panic attacks, agitation, and severe insomnia often precede suicide within hours, days, or weeks and can be rapidly modified with treatment?

On the other hand, standard risk factors for suicide such as suicidal ideation, hopelessness, and past suicidal attempts are not good predictors of suicide in the short term. A suicide plan, recent high intent attempt, or refusal to contract for safety may well indicate immediate risk, but a denial of suicidal ideation or intent and a contract for no harm mean absolutely nothing without a full suicide assessment that takes current clinical status, past suicidal tendencies, social support, and willingness to accept help into account.

Type
Introduction
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Fawcett, J, Scheftner, WA, Fogg, L. Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990;147:11891194.Google ScholarPubMed
2.Gladstone, GL, Mitchell, PB, Parker, G, et al.Indicators of suicide over 10 years in a specialist mood disorders unit sample. J Clin Psychiatry. 2001;6:945951.CrossRefGoogle Scholar
3.Busch, KA, Fawcett, J, Jacobs, DG. Clinical correlates of inpatient suicide. J Clin Psychiatry. 2003:64:1419.CrossRefGoogle ScholarPubMed
4.Hall, RC, Platt, DE, Hall, RC. Suicide risk assessment a review of risk factors for suicide in 100 patients who made severe suicide attempts. Evaluation of suicide risk in a time of managed care. Psychosomatics. 1999;40:1827.CrossRefGoogle Scholar
5.American Psychiatric Association. Practice Guidelines for the Treatment of Psychiatric Disorders Compendium. Arlington, Va; 2004.Google Scholar
6.Khan, A, Khan, S, Kolts, R, Brown, WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry. 2003;160:790792.CrossRefGoogle ScholarPubMed
7.Angst, F, Stassen, HH, Clayton, PJ, Angst, J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002;68:167181.CrossRefGoogle ScholarPubMed
8.Angst, J, Angst, F, Gerber-Werder, R, Gamma, A. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years follow-up. Arch Suicide Res. 2005;9:279300.CrossRefGoogle ScholarPubMed